Cancer detection technology specialist, Verisante Technology has confirmed that the company has won new purchase orders for Verisante Aura from the company's exclusive distributors in Canada and Europe.
According to the company, Aura is the only device that can detect all major types of skin cancer and the only device that has been developed by a government cancer agency and a leading university dermatology department.
Developed by a team of leading specialists, Aura is built to rapidly and safely aid in the detection of skin cancer when held above a suspicious mole or lesion. Even if a mole or lesion looks normal to the naked eye, an AuraScan will help your doctor identify it.
With the new purchase order sailing in, the company plans to ship Aura devices in February and the company officials said that they will update the new Aura website with a list of clinics where patients can go to request an AuraScan when installations have been completed.
"This is a significant achievement for our Company as we take this ground-breaking technology to full commercialization," said Thomas Braun, president & CEO of Verisante. "The Company has been working very closely with our distribution partners on a strategic product launch. With manufacturing of Aura™ now underway and the full support of our distributors, 2013 is already shaping up to be a very successful year for our company."
Aura is built to work like a non-invasive optical system that utilizes Raman spectroscopy to biochemically analyze the skin, providing immediate and accurate results. The device will help to automate the current process of diagnosis, allowing rapid scanning of the 20 to 40 skin lesions on at-risk individuals, improving patient outcomes and comfort.
“Aura has the potential to revolutionize the way skin cancer is diagnosed," said Dan Webb, CEO of Clarion, exclusive Canadian distributor. "Clarion is committed to bringing this life-saving technology to medical professionals across Canada."
Verisante is a medical device company committed to commercializing innovative systems for the early detection of cancer
Source: http://www.healthtechzone.com
-
APN Health, a firm based in Wisconsin, got hold of an FDA clearance to introduce its Navik 3D cardiac mapping system in the U.S. The system... -
Every mammal on this planet starts in the same way: a sperm encounters an egg and fuses with it. This process is familiar to every eighth gr... -
As the number of joint replacement surgeries grows, so do concerns about the complications of infection from antibiotic-resistant superbugs...
0 comments:
Post a Comment